Found 65 clinical trials
-
Accepting Seniors
-
Accepting adults
-
An observational study
-
For all genders
-
Currently Recruiting
Stroke Prevention in Atrial Fibrillation Patients Between 2004 and 2020
rates of bleeding, especially intracranial haemorrhage. The aim of this study was to assess the frequency of oral anticoagulants using, espescially apixaban, dabigatran, and rivaroxaban, and the
- 0 views
- 29 Jan, 2021
- 2 locations
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Sub-Clinical Atrial Fibrillation Biomarker Study
This is a sub-study of the ARTESiA study registered as NCT01938248. This study is designed to validate biomarkers in subclinical atrial fibrillation and to determine if the prospective biomarker will be informative of the potential efficacy of treatment.
- 8 views
- 24 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
A Multi-center Study of Apixaban(APPROACH)
The aim of the study is to enroll approximately 200 cases from 10 research centers nationwide, completed left atrial appendage occlusion (LAAO) successfully, and give apixaban (5 mg bid
- 0 views
- 25 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Specific PoC Testing of Coagulation in Patients Treated With DOAC 1
The investigators study aims to test the correlation between the Cascade Abrazo point-of-care testing (POCT) device (Helena Laboratories, USA) and plasma levels of apixaban, dabigatran, edoxaban
- 0 views
- 27 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Impact of Biomarkers on Pharmacokinetics and Pharmacodynamics of Direct Oral Anticoagulants
(include rivaroxaban, apixaban, dabigatran and so on) have advantages of convenient use and no need of monitoring, compared with the traditional vitamin K antagonist. With lack of predicted biomarkers
- 7 views
- 28 Jan, 2021
- 21 locations
-
Accepting Seniors
-
Accepting adults
-
100s of participants
-
An observational study
-
For all genders
-
Cardiology/Vascular Diseases
-
Currently Recruiting
Antithrombotics' Therapeutic Optimization in Hospitalized Patients Using Physiologically- and Population-based Pharmacokinetic Modeling
The main goal of the OptimAT study main goal is to validate a PBPK model for 3 direct oral anticoagulants (rivaroxaban, apixaban, dabigatran) and 3 P2Y12 inhibitors (clopidogrel, ticagrelor
- 0 views
- 22 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
Real-life Clinical Outcomes of Direct Oral Anticoagulants (MACACOD)
MACACOD is a clinical record in the usual clinical practice of direct oral anticoagulants (dabigatran, rivaroxaban, apixaban and edoxaban). Design: single-center, observational, prospective
- 2 views
- 24 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
Non-Interventional Study on Effectiveness of Elxaban Tab. in Patients With Non-valvular Atrial Fibrillation
apixaban) who visit hospital. The purpose is to analyze bleeding (major bleeding, minor bleeding), stroke, systemic embolism, death, other clinical events (acute myocardial infarction, pulmonary embolism
- 3 views
- 23 Jan, 2021
- 1 location
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Pediatrics/Neonatology
-
Currently Recruiting
Atrial Fibrillation Research Database
All patients with atrial fibrillation who are treated with vitamin-k antagonists (warfarin, phenprocoumon) or non vitamin K oral anticoagulants (Dabigatran, Rivaroxaban, Apixaban, Edoxaban) in
- 2 views
- 24 Jan, 2021
- 2 locations
-
Accepting Seniors
-
Accepting adults
-
1000s of participants
-
An observational study
-
For all genders
-
Currently Recruiting
Registry of Patients Prescribed Anticoagulation
" agents: warfarin and heparinoids and the newer direct oral anticoagulants (DOACs) such as rivaroxaban, dabigatran, apixaban, and edoxaban.
- 17 views
- 25 Jan, 2021
- 1 location